Atlas Trials

First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133

Clinical trial NCT06290557 · RECRUITING

Trial details

NCT number
NCT06290557
Sponsor
University Hospital Tuebingen
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Staphylococcus Aureus
Start date
2024-07-10
Primary completion
2025-07-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.